Toll Free: 1-888-928-9744
Published: Dec, 2015 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Clearside BioMedical, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Clearside BioMedical, Inc. - Product Pipeline Review - 2015', provides an overview of the Clearside BioMedical, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Clearside BioMedical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Clearside BioMedical, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Clearside BioMedical, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Clearside BioMedical, Inc.'s pipeline products Reasons To Buy - Evaluate Clearside BioMedical, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Clearside BioMedical, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Clearside BioMedical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Clearside BioMedical, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Clearside BioMedical, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Clearside BioMedical, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Clearside BioMedical, Inc. Snapshot 5 Clearside BioMedical, Inc. Overview 5 Key Information 5 Key Facts 5 Clearside BioMedical, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Clearside BioMedical, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Clearside BioMedical, Inc. - Pipeline Products Glance 11 Clearside BioMedical, Inc. - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Clearside BioMedical, Inc. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Clearside BioMedical, Inc. - Early Stage Pipeline Products 13 Discovery Products/Combination Treatment Modalities 13 Clearside BioMedical, Inc. - Drug Profiles 14 triamcinolone acetonide 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 (triamcinolone acetonide + aflibercept) 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Small Molecules to Inhibit VEGF and PDGF for Wet AMD 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Small Molecules to Inhibit VEGF for Wet AMD 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Clearside BioMedical, Inc. - Pipeline Analysis 20 Clearside BioMedical, Inc. - Pipeline Products by Target 20 Clearside BioMedical, Inc. - Pipeline Products by Route of Administration 21 Clearside BioMedical, Inc. - Pipeline Products by Molecule Type 22 Clearside BioMedical, Inc. - Pipeline Products by Mechanism of Action 23 Clearside BioMedical, Inc. - Recent Pipeline Updates 24 Clearside BioMedical, Inc. - Dormant Projects 26 Clearside BioMedical, Inc. - Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29
List of Tables
Clearside BioMedical, Inc., Key Information 5 Clearside BioMedical, Inc., Key Facts 5 Clearside BioMedical, Inc. - Pipeline by Indication, 2015 7 Clearside BioMedical, Inc. - Pipeline by Stage of Development, 2015 8 Clearside BioMedical, Inc. - Monotherapy Products in Pipeline, 2015 9 Clearside BioMedical, Inc. - Combination Treatment Modalities in Pipeline, 2015 10 Clearside BioMedical, Inc. - Phase III, 2015 11 Clearside BioMedical, Inc. - Phase II, 2015 12 Clearside BioMedical, Inc. - Discovery, 2015 13 Clearside BioMedical, Inc. - Pipeline by Target, 2015 20 Clearside BioMedical, Inc. - Pipeline by Route of Administration, 2015 21 Clearside BioMedical, Inc. - Pipeline by Molecule Type, 2015 22 Clearside BioMedical, Inc. - Pipeline Products by Mechanism of Action, 2015 23 Clearside BioMedical, Inc. - Recent Pipeline Updates, 2015 24 Clearside BioMedical, Inc. - Dormant Developmental Projects,2015 26 Clearside BioMedical, Inc., Other Locations 27
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.